Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 959 products on this category.

Product data	Purity	Price range	Estimated delivery
Palbociclib REF: 86-MM3729.00-0250CAS: 571190-30-2	- - -	2,214.00 €	Wed 04 Dec 24
7α-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfonyl]nonyl]estra-1,3,5(10)-triene-3,17β-diol (Fulvestrant Sulfone) REF: 86-MM3296.01-0025CAS: 98008-06-1	- - -	1,033.00 €	Wed 04 Dec 24
Fulvestrant REF: 86-MM3296.00CAS: 129453-61-8	- - -	295.00 €	Wed 04 Dec 24
1-(Cyclopropylcarbonyl)piperazine Hydrochloride REF: 86-MM3926.01-0025CAS: 1021298-67-8	- - -	To inquire	Wed 04 Dec 24
N-Nitrosopalbociclib REF: 86-MM3729.01-0025	- - -	2,088.00 €	Wed 04 Dec 24
2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzonitrile REF: 86-MM3926.07-0025CAS: 1021298-68-9	- - -	To inquire	Wed 04 Dec 24
Folinic acid REF: TM-T24403CAS: 58-05-9	99.7%	36.00 €~222.00 €	Wed 04 Dec 24
Carfilzomib Impurity 41 REF: 4Z-C-121044	- - -	To inquire	Tue 10 Dec 24
Palbociclib Impurity 84 REF: 4Z-P-196095CAS: 1374639-76-5	- - -	To inquire	Tue 10 Dec 24
N-Nitroso Palbociclib Impurity 53 REF: 4Z-P-196094	- - -	To inquire	Tue 10 Dec 24
N-Nitroso Palbociclib Impurity 84 REF: 4Z-P-196096	- - -	To inquire	Tue 10 Dec 24
N-Nitroso Enzalutamide Impurity 16 REF: 4Z-E-068075	- - -	To inquire	Tue 10 Dec 24
N1,N2-Di-N-Nitroso Nintedanib Impurity 4 REF: 4Z-N-066120	- - -	To inquire	Tue 10 Dec 24
Olaparib Impurity 82 REF: 4Z-O-032091CAS: 763111-46-2	- - -	To inquire	Tue 10 Dec 24
N-Nitroso Olaparib Impurity 82 REF: 4Z-O-032092	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 105 REF: 4Z-N-066121	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 106 REF: 4Z-N-066122CAS: 637-98-9	- - -	To inquire	Tue 10 Dec 24
Palbociclib Impurity 89 REF: 4Z-P-196105CAS: 2639903-34-5	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 107 REF: 4Z-N-066123CAS: 707-07-3	- - -	To inquire	Tue 10 Dec 24
N1,N3-Dinitroso (6R)-Folinic Acid Impurity 1 REF: 4Z-F-068038	- - -	To inquire	Tue 10 Dec 24

10mg		39.00 €
25mg		54.00 €
50mg		76.00 €
100mg		97.00 €
500mg		222.00 €

Cancer treatment

Palbociclib

Ref: 86-MM3729.00-0250

7α-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfonyl]nonyl]estra-1,3,5(10)-triene-3,17β-diol (Fulvestrant Sulfone)

Ref: 86-MM3296.01-0025

Fulvestrant

Ref: 86-MM3296.00

1-(Cyclopropylcarbonyl)piperazine Hydrochloride

Ref: 86-MM3926.01-0025

N-Nitrosopalbociclib

Ref: 86-MM3729.01-0025

2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzonitrile

Ref: 86-MM3926.07-0025

Folinic acid

Ref: TM-T24403

Carfilzomib Impurity 41

Ref: 4Z-C-121044

Palbociclib Impurity 84

Ref: 4Z-P-196095

N-Nitroso Palbociclib Impurity 53

Ref: 4Z-P-196094

N-Nitroso Palbociclib Impurity 84

Ref: 4Z-P-196096

N-Nitroso Enzalutamide Impurity 16

Ref: 4Z-E-068075

N1,N2-Di-N-Nitroso Nintedanib Impurity 4

Ref: 4Z-N-066120

Olaparib Impurity 82

Ref: 4Z-O-032091

N-Nitroso Olaparib Impurity 82

Ref: 4Z-O-032092

Nintedanib Impurity 105

Ref: 4Z-N-066121

Nintedanib Impurity 106

Ref: 4Z-N-066122

Palbociclib Impurity 89

Ref: 4Z-P-196105

Nintedanib Impurity 107

Ref: 4Z-N-066123

N1,N3-Dinitroso (6R)-Folinic Acid Impurity 1

Ref: 4Z-F-068038